NexImmune Inc. Gains 31.06%
Thu, Mar 24, 2022 at 05:30 PM
NexImmune Inc. (NEXI:NASDAQ) soared at $3.46, representing a gain of 31.1%. On Wed, Mar 23, 2022, NEXI:NASDAQ touched a New 2-Week Intraday High of $2.82. The stock got featured on our News Catalysts scanner on Thu, Mar 17, 2022 at 08:02 AM in the 'PATNERSHIP' category. From Thu, Mar 10, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
About NexImmune Inc. (NEXI:NASDAQ)
NexImmune Inc is a clinical-stage biotechnology company engaged in developing immunotherapy to employ the body's T cells to generate an immune response that mimics natural biology.
Top 10 Gainers:
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 39.07%
- Global Internet of People Inc. (SDH:NASDAQ), 38.35%
- AgriFORCE Growing Systems Ltd. (AGRI:NASDAQ), 34.89%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 33.67%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 32.82%
- Emclaire Financial Corp (EMCF:NASDAQ), 32.17%
- cbdMD, Inc. (YCBD:NYSEMKT), 31.33%
- NexImmune Inc. (NEXI:NASDAQ), 31.06%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 30.48%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 29.51%